Intervention Review

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease

  1. Julia AE Walters1,*,
  2. Wendy Wang2,
  3. Carla Morley2,
  4. Amir Soltani2,
  5. Richard Wood-Baker1

Editorial Group: Cochrane Airways Group

Published Online: 5 OCT 2011

Assessed as up-to-date: 27 APR 2011

DOI: 10.1002/14651858.CD006897.pub2

How to Cite

Walters JAE, Wang W, Morley C, Soltani A, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD006897. DOI: 10.1002/14651858.CD006897.pub2.

Author Information

  1. 1

    University of Tasmania, Menzies Research Institute Tasmania, Hobart, Tasmania, Australia

  2. 2

    University of Tasmania, Hobart, Tasmania, Australia

*Julia AE Walters, Menzies Research Institute Tasmania, University of Tasmania, MS1, 17 Liverpool Street, PO Box 23, Hobart, Tasmania, 7001, Australia. Julia.Walters@utas.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 5 OCT 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Brian J. Harte, David Wesorick, Andrew Odden, Chronic Obstructive Pulmonary Disease, Hospital Medicine Clinics, 2013, 2, 2, e169

    CrossRef

  2. 2
    Heikki O Koskela, Päivi H Salonen, Leo Niskanen, Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease, The Clinical Respiratory Journal, 2013, 7, 4